Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd has been growing earnings at an average annual rate of 39.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 26.3% per year. Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd's return on equity is 14.2%, and it has net margins of 11.6%.
Belangrijke informatie
39.6%
Groei van de winst
32.7%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.1% |
| Inkomstengroei | 26.3% |
| Rendement op eigen vermogen | 14.2% |
| Nettomarge | 11.6% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 6,192 | 718 | 412 | 22 |
| 30 Jun 24 | 6,163 | 744 | 385 | 24 |
| 31 Mar 24 | 6,377 | 750 | 395 | 26 |
| 31 Dec 23 | 7,021 | 854 | 405 | 29 |
| 30 Sep 23 | 6,646 | 748 | 390 | 44 |
| 30 Jun 23 | 6,858 | 723 | 394 | 42 |
| 31 Mar 23 | 7,174 | 730 | 392 | 44 |
| 31 Dec 22 | 6,903 | 666 | 391 | 46 |
| 30 Sep 22 | 9,351 | 979 | 497 | 42 |
| 30 Jun 22 | 8,172 | 833 | 444 | 35 |
| 31 Mar 22 | 6,569 | 579 | 404 | 32 |
| 31 Dec 21 | 5,568 | 443 | 353 | 27 |
| 30 Sep 21 | 2,558 | 133 | 201 | 10 |
| 30 Jun 21 | 2,507 | 148 | 207 | 10 |
| 31 Mar 21 | 2,459 | 170 | 196 | 9 |
| 31 Dec 20 | 2,067 | 107 | 187 | 8 |
| 30 Sep 20 | 1,893 | 99 | 177 | 4 |
| 30 Jun 20 | 1,921 | 92 | 177 | 8 |
| 31 Mar 20 | 1,979 | 82 | 179 | 7 |
| 31 Dec 19 | 2,135 | 95 | 188 | 7 |
| 30 Sep 19 | 2,221 | 98 | 196 | 10 |
| 30 Jun 19 | 2,078 | 66 | 190 | 6 |
| 31 Mar 19 | 2,055 | 50 | 178 | 5 |
| 31 Dec 18 | 2,034 | 52 | 179 | 5 |
| 30 Sep 18 | 1,858 | 32 | 182 | 3 |
| 30 Jun 18 | 1,635 | 24 | 167 | 2 |
| 31 Mar 18 | 1,431 | 25 | 176 | 2 |
| 01 Jan 18 | 1,273 | 18 | 174 | 2 |
| 30 Sep 17 | 1,171 | 3 | 220 | 1 |
| 30 Jun 17 | 1,035 | -38 | 233 | 0 |
| 31 Mar 17 | 950 | -46 | 222 | 0 |
| 31 Dec 16 | 928 | -25 | 227 | 0 |
| 30 Sep 16 | 854 | -3 | 150 | 0 |
| 30 Jun 16 | 862 | 35 | 155 | 0 |
| 31 Mar 16 | 869 | 103 | 147 | 0 |
| 31 Dec 15 | 859 | 95 | 137 | 0 |
| 30 Sep 15 | 864 | 119 | 166 | 0 |
| 30 Jun 15 | 896 | 132 | 158 | 0 |
| 31 Mar 15 | 920 | 104 | 157 | 0 |
| 31 Dec 14 | 909 | 87 | 162 | 0 |
| 31 Dec 13 | 1,058 | 96 | 173 | 0 |
Kwaliteitswinsten: 603227 has high quality earnings.
Groeiende winstmarge: 603227's current net profit margins (11.6%) are higher than last year (11.3%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 603227's earnings have grown significantly by 39.6% per year over the past 5 years.
Versnelling van de groei: 603227's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 603227 had negative earnings growth (-4%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendement op eigen vermogen
Hoge ROE: 603227's Return on Equity (14.2%) is considered low.